AeroLeads people directory · profile
Mark Arnold Email & Phone Number
Consulting with biotech and pharma to bring new therapies to patients in need
at
Alchemi
1 work email found
@bms.com
2 phones found area 732 and 203
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Consulting with biotech and pharma to bring new therapies to patients in need
Location
Mount Holly, New Jersey, United States
Who is Mark Arnold? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Mark Arnold is listed as Consulting with biotech and pharma to bring new therapies to patients in need at Alchemi, based in Mount Holly, New Jersey, United States. AeroLeads shows a work email signal at bms.com, phone signal with area code 732, 203, and a matched LinkedIn profile for Mark Arnold.
Mark Arnold previously worked as Managing Director at Bioanalytical Solution Integration and Director of Science at Labcorp Drug Development. Mark Arnold holds Ph.D., Pharmacology & Toxicology from University Of Pittsburgh.
Company email context
Email format at Alchemi
This section adds company-level context without repeating Mark Arnold's masked contact details.
{first}.{last}@bms.com
86% confidence
AeroLeads found 1 current-domain work email signal for Mark Arnold. Compare company email patterns before reaching out.
Profile bio
About Mark Arnold
Bioanalytical thought leader with extensive experience and a demonstrated record of success in supporting drug development programs from IND through NDA/BLA with integrated solutions. Specific expertise in drug, metabolite and biomarker measurements using liquid chromatography mass spectrometry and immunochemistry-based assays in support of globally-regulated nonclinical and clinical studies. Global compliance experience with GLP, GCP, GCLP and CLIA for both regional and ICH regulations. Executed and managed bioanalytical content for FDA and international filings. Bioanalytical Solution Integration ♦ Regulatory Compliance Expertise Strategic Planning ♦ Change Management ♦ CRO Integration ♦ Talent Development Involved in the ♦ AAPS ♦ Inducted as AAPS Fellow (2014) ♦ Chair of the Scientific Advisory Committee ♦ 2021 Scientific Program Chair for the PharmSci360 Conference ♦ Member of several Communities ♦ CPSA 4-Corners Conversation speaker and moderator ♦ Founder and Steering Committee member of the Global Bioanalysis ConsortiumSpecialties: BioanalysisLC-MS/MSImmunoassaysMicrosamplingAccelerator mass spectrometryBiomarkersPCRGLP, GCLP, GCP, CLIA and related bioanalytical regulations
Listed skills include Drug Development, Glp, Bioanalysis, Drug Discovery, and 37 others.
Current workplace
Mark Arnold's current company
Company context helps verify the profile and gives searchers a useful next step.
16 roles
Mark Arnold work experience
A career timeline built from the work history available for this profile.
Managing Director
Current
Bioanalytical Solution Integration
Exploring the translational research and bioanalytical continuum.Providing strategic counsel and management for complex bioanalytical assays to quantify small molecule, oligo, peptides, protein drugs, antibodies, gene and cell therapies under GLP, GCP and CLIA. Additionally, providing guidance on integrated solutions for the measurement of clinical.
May 2016 - Present
Director Of Science
Covance has become Labcorp Drug DevelopmentThe Clinical Trials Testing Solution's (CTTS) Scientific Affairs Group's role is to use our experience and know how to help our clients hit their milestones. My responsibility is to collaborate with Bioanalytical, BioPharmCMC and Clinical Lab Solutions leadership to develop and drive a harmonized strategy that.
Aug 2018 - Jan 2023
Director - Site Lead
Site leader for full-service bioanalytical laboratory supporting the pharmaceutical industry. Capabilities include immunochemistry, cell-based andLC-MS assays for discovery, preclinical and clinical studies.
Sep 2016 - Jul 2018
Executive Director
- Led and managed two departments within the development portion R&D, delivering quantitative measures of new drug candidates and biomarkers to support nonclinical (GLP) and clinical (GCLP) translational research..
- Expanded Bioanalytical Sciences’ role in implementing complex bioanalytical LC-MS/MS assays to quantify small molecules, including oligonucleotides, millamolecules, protein drugs and biomarkers, providing essential.
- Developed and maintained productive relationships with collaborating departments (drug safety, metabolism and pharmacokinetics, regulatory compliance, clinical, pharmacokinetics) and project working groups through.
- Actively developed staff through training, coaching and mentoring in scientific, technical, regulatory areas. Hired and retained leading bioanalytical scientists and managers.
- Oversaw and guided departmental compliance practices and standard operating procedures (SOPSs) ensuring alignment with emerging regulations (FDA, EMA, MHLW) and thinking.
- Operated as bioanalytical due diligence and acquisition integration lead.
Apr 2013 - May 2016
Group Director
- Provided strategic leadership and managed all development facing immunoassay and LC-MS bioanalytical, including outsourced work to quantify small molecule, oligonucleotides, protein drugs and related compounds in a.
- Guided bioanalytical scientific program support with leading-edge technologies for R&D’s development portfolio for multiple yearly NDA and sNDA filings.
- Contributed to efficiency and process improvement initiatives for clinical pharmacokinetic data management through Kaizen events, shortening the timeline by 4 person-weeks per study.
- Rotational leadership of four Chemistry, Manufacturing, and Controls analytical teams: Industrial Hygiene, Analytical Strategic Operations, Microbiology and an Analytical Project Team (2013); learning the GMP-side of.
- Monitored global regulatory changes and implemented compliant internal practices that aligned internal and contracted work.
- Contributed to the external scientific and regulatory community through active membership in five scientific organizations. Regularly published, presented and participated in scientific conferences and forums..
Feb 2007 - Mar 2013
Director
- Provided scientific and strategic leadership of Bioanalytical Sciences, including immunochemistry, immunogenicity, externalized science and late stage program development. Development team program representative for.
- Tripled the immunochemistry group size, and implemented new technology and procedures to deliver enhanced pharmacokinetic and immunogenicity assay capabilities.
- Identified and contributed to continuous improvement process changes that generated $500K in savings and shortened the IND timeline, and improved quality and compliance.
- Expanded external membership in the Steering Committee for the Bioanalytical Focus Group of the American Association of Pharmaceutical Scientists (AAPS) and the Planning Committee for the Land O’Lakes Bioanalytical.
Nov 2003 - Jan 2007
Associate Director
Nov 2001 - Nov 2003
Group Leader
Sep 1998 - Nov 2001
Senior Research Investigator Ii
Feb 1994 - Sep 1998
Senior Research Investigator
Sep 1988 - Feb 1994
Research Investigator
Sep 1986 - Sep 1988
Senior Scientist
Schering-Plough Animal Health Research Center
Developed extraction procedures for drugs and metabolites in biological fluids and tissues for analysis by HPLC (UV and radiochemical) and GC (NPD). Supervised a group of three professional scientists in their daily routine. Designed, conducted, analyzed and reported on in vivo and in vitro (aerobic and anaerobic) metabolic studies. Performed.
Jun 1985 - Aug 1986
Teaching Fellow
Responsible for preparing and presenting laboratory instruction and directing laboratory activities to Pharmacy students. Presented lectures on human pharmacology as needed.
Sep 1980 - Mar 1985
Consultant
Union Carbide Corporation
Departments of Genetic Toxicology, Teratology and Skin Carcinogenicity
May 1982 - Sep 1982
Intern Coal And Water Analysis Technician
Rochester And Pittsburgh Coal Company
Collected and analyzed water and coal samples from a variety of sources in the Indiana area. Coal assays included measurement of sulfur and calorimetric content. Water, from operating mines and as part of site reclamation procedures, was tested for dissolved minerals, buffers, solids and pH.
May 1979 - Aug 1979
2 education records
Mark Arnold education
Ph.D., Pharmacology & Toxicology
University Of Pittsburgh
B.S., Biology
Indiana University Of Pennsylvania
FAQ
Frequently asked questions about Mark Arnold
Quick answers generated from the profile data available on this page.
What company does Mark Arnold work for?
Mark Arnold works for Alchemi.
What is Mark Arnold's role at Alchemi?
Mark Arnold is listed as Consulting with biotech and pharma to bring new therapies to patients in need at Alchemi.
What is Mark Arnold's email address?
AeroLeads has found 1 work email signal at @bms.com for Mark Arnold at Alchemi.
What is Mark Arnold's phone number?
AeroLeads has found 2 phone signal(s) with area code 732, 203 for Mark Arnold at Alchemi.
Where is Mark Arnold based?
Mark Arnold is based in Mount Holly, New Jersey, United States while working with Alchemi.
What companies has Mark Arnold worked for?
Mark Arnold has worked for Alchemi, Bioanalytical Solution Integration, Labcorp Drug Development, Covance, and Bristol-Myers Squibb.
How can I contact Mark Arnold?
You can use AeroLeads to view verified contact signals for Mark Arnold at Alchemi, including work email, phone, and LinkedIn data when available.
What schools did Mark Arnold attend?
Mark Arnold holds Ph.D., Pharmacology & Toxicology from University Of Pittsburgh.
What skills is Mark Arnold known for?
Mark Arnold is listed with skills including Drug Development, Glp, Bioanalysis, Drug Discovery, Pharmaceutical Industry, Hplc, Cro, and Lc Ms.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial